tetano
Editor, Senior Moderator
Signal Transduct Target Ther
. 2024 Jul 19;9(1):180.
doi: 10.1038/s41392-024-01898-x. Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection
Xuan He[SUP] #[/SUP][SUP] 1 [/SUP], Jingyou Yu[SUP] #[/SUP][SUP] 2 [/SUP], Jiajing Jiang[SUP] #[/SUP][SUP] 3 [/SUP], Jinyuan Liu[SUP] 3 [/SUP], Qi Qi[SUP] 4 [/SUP], Dan Liu[SUP] 5 [/SUP], Weimin Li[SUP] 6 [/SUP]
Affiliations
. 2024 Jul 19;9(1):180.
doi: 10.1038/s41392-024-01898-x. Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection
Xuan He[SUP] #[/SUP][SUP] 1 [/SUP], Jingyou Yu[SUP] #[/SUP][SUP] 2 [/SUP], Jiajing Jiang[SUP] #[/SUP][SUP] 3 [/SUP], Jinyuan Liu[SUP] 3 [/SUP], Qi Qi[SUP] 4 [/SUP], Dan Liu[SUP] 5 [/SUP], Weimin Li[SUP] 6 [/SUP]
Affiliations
- PMID: 39025834
- DOI: 10.1038/s41392-024-01898-x